The Tumor Suppressor BCL7B Functions in the Wnt Signaling Pathway

1. HasleH, OlsenJH, HansenJ, FriedrichU, TommerupN (1998) Occurrence of cancer in a cohort of 183 persons with constitutional chromosome 7 abnormalities. Cancer Genet Cytogenet 105: 39–42.

2. HillierLW, FultonRS, FultonLA, GravesTA, PepinKH, et al. (2003) The DNA sequence of human chromosome 7. Nature 424: 157–164.

3. Le BeauMM, EspinosaR, DavisEM, EisenbartJD, LarsonRA, et al. (1996) Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88: 1930–1935.

4. ZenklusenJC, ContiCJ (1996) Cytogenetic, molecular and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7. Mol Carcinog 15: 167–175.

5. AmentaS, MoschoviM, SofocleousC, KostaridouS, MavrouA, et al. (2004) Non-Hodgkin lymphoma in a child with Williams syndrome. Cancer Genet Cytogenet 154: 86–88.

6. CulicV, CulicS, ArmandaV, ResicB, LasanR, et al. (2002) Single signal of the Williams syndrome chromosome region 1 gene in hyperploidic bone marrow cells of acute lymphoblastic leukemia in a Williams syndrome patient. Med Pediatr Oncol 38: 205–207.

7. OnimoeGI, KahwashS, TermuhlenA, GrossTG, VargaE, et al. (2011) Bilateral burkitt lymphoma of the ovaries: a report of a case in a child with williams syndrome. Case Rep Med 2011: 327263.

8. ThornburgCD, RoulstonD, CastleVP (2005) Burkitt lymphoma and Williams syndrome: a model for children with a multisystem disorder and malignancy. J Pediatr Hematol Oncol 27: 109–111.

9. ZhukovaN, NaqviA (2013) Williams-Beuren Syndrome and Burkitt Leukemia. J Pediatr Hematol Oncol 35: e30–32.

10. JadayelDM, OsborneLR, CoignetLJ, ZaniVJ, TsuiLC, et al. (1998) The BCL7 gene family: deletion of BCL7B in Williams syndrome. Gene 224: 35–44.

11. PotterN, KarakoulaA, PhippsKP, HarknessW, HaywardR, et al. (2008) Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma. Neoplasia 10: 757–772.

12. ZaniVJ, AsouN, JadayelD, HewardJM, ShipleyJ, et al. (1996) Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood 87: 3124–3134.

13. MortonLM, PurdueMP, ZhengT, WangSS, ArmstrongB, et al. (2009) Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 18: 1259–1270.

14. CarboneA, BernardiniL, ValenzanoF, BottilloI, De SimoneC, et al. (2008) Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF. Genes Chromosomes Cancer 47: 1067–1075.

15. van DoornR, ZoutmanWH, DijkmanR, de MenezesRX, CommandeurS, et al. (2005) Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 23: 3886–3896.

16. SekiguchiM, SakakibaraK, FujiiG (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61–68.

17. AmbrosV, HorvitzHR (1984) Heterochronic mutants of the nematode Caenorhabditis elegans. Science 226: 409–416.

18. KohK, RothmanJH (2001) ELT-5 and ELT-6 are required continuously to regulate epidermal seam cell differentiation and cell fusion in C. elegans. Development 128: 2867–2880.

19. ClucasC, CabelloJ, BüssingI, SchnabelR, JohnstoneIL (2002) Oncogenic potential of a C.elegans cdc25 gene is demonstrated by a gain-of-function allele. EMBO J 21: 665–674.

20. KarpX, GreenwaldI (2004) Multiple roles for the E/Daughterless ortholog HLH-2 during C. elegans gonadogenesis. Dev Biol 272: 460–469.

21. YuanJ, ShahamS, LedouxS, EllisHM, HorvitzHR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641–652.

22. MossEG (2007) Heterochronic genes and the nature of developmental time. Curr Biol 17: R425–434.

23. SulstonJE, HorvitzHR (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56: 110–156.

24. AbrahanteJE, MillerEA, RougvieAE (1998) Identification of heterochronic mutants in Caenorhabditis elegans. Temporal misexpression of a collagen::green fluorescent protein fusion gene. Genetics 149: 1335–1351.

25. LiuZ, KirchS, AmbrosV (1995) The Caenorhabditis elegans heterochronic gene pathway controls stage-specific transcription of collagen genes. Development 121: 2471–2478.

26. SmithCJ, O'BrienT, ChatzigeorgiouM, SpencerWC, Feingold-LinkE, et al. (2013) Sensory neuron fates are distinguished by a transcriptional switch that regulates dendrite branch stabilization. Neuron 79: 266–280.

27. TreininM, GilloB, LiebmanL, ChalfieM (1998) Two functionally dependent acetylcholine subunits are encoded in a single Caenorhabditis elegans operon. Proc Natl Acad Sci U S A 95: 15492–15495.

28. HermanMA, HorvitzHR (1994) The Caenorhabditis elegans gene lin-44 controls the polarity of asymmetric cell divisions. Development 120: 1035–1047.

29. KagiasK, AhierA, FischerN, JarriaultS (2012) Members of the NODE (Nanog and Oct4-associated deacetylase) complex and SOX-2 promote the initiation of a natural cellular reprogramming event in vivo. Proc Natl Acad Sci U S A 109: 6596–6601.

30. TenenhausC, SubramaniamK, DunnMA, SeydouxG (2001) PIE-1 is a bifunctional protein that regulates maternal and zygotic gene expression in the embryonic germ line of Caenorhabditis elegans. Genes Dev 15: 1031–1040.

31. HsuJY, SunZW, LiX, ReubenM, TatchellK, et al. (2000) Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102: 279–291.

32. KillianDJ, HubbardEJ (2005) Caenorhabditis elegans germline patterning requires coordinated development of the somatic gonadal sheath and the germ line. Dev Biol 279: 322–335.

33. HallDH, WinfreyVP, BlaeuerG, HoffmanLH, FurutaT, et al. (1999) Ultrastructural features of the adult hermaphrodite gonad of Caenorhabditis elegans: relations between the germ line and soma. Dev Biol 212: 101–123.

34. VoutevR, KeatingR, HubbardEJ, VallierLG (2009) Characterization of the Caenorhabditis elegans Islet LIM-homeodomain ortholog, lim-7. FEBS Lett 583: 456–464.

35. HendersonST, GaoD, LambieEJ, KimbleJ (1994) lag-2 may encode a signaling ligand for the GLP-1 and LIN-12 receptors of C. elegans. Development 120: 2913–2924.

36. HendersonST, GaoD, ChristensenS, KimbleJ (1997) Functional domains of LAG-2, a putative signaling ligand for LIN-12 and GLP-1 receptors in Caenorhabditis elegans. Mol Biol Cell 8: 1751–1762.

37. BlellochR, Anna-ArriolaSS, GaoD, LiY, HodgkinJ, et al. (1999) The gon-1 gene is required for gonadal morphogenesis in Caenorhabditis elegans. Dev Biol 216: 382–393.

38. BulinaME, LukyanovKA, BritanovaOV, OnichtchoukD, LukyanovS, et al. (2006) Chromophore-assisted light inactivation (CALI) using the phototoxic fluorescent protein KillerRed. Nat Protoc 1: 947–953.

39. YoshinaS, SakakiK, Yonezumi-HayashiA, Gengyo-AndoK, InoueH, et al. (2012) Identification of a novel ADAMTS9/GON-1 function for protein transport from the ER to the Golgi. Mol Biol Cell 23: 1728–1741.

40. EisenmannDM, MaloofJN, SimskeJS, KenyonC, KimSK (1998) The beta-catenin homolog BAR-1 and LET-60 Ras coordinately regulate the Hox gene lin-39 during Caenorhabditis elegans vulval development. Development 125: 3667–3680.

41. MeneghiniMD, IshitaniT, CarterJC, HisamotoN, Ninomiya-TsujiJ, et al. (1999) MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399: 793–797.

42. NatarajanL, WitwerNE, EisenmannDM (2001) The divergent Caenorhabditis elegans beta-catenin proteins BAR-1, WRM-1 and HMP-2 make distinct protein interactions but retain functional redundancy in vivo. Genetics 159: 159–172.

43. FlowersEB, PooleRJ, TursunB, BashllariE, Pe'erI, et al. (2010) The Groucho ortholog UNC-37 interacts with the short Groucho-like protein LSY-22 to control developmental decisions in C. elegans. Development 137: 1799–1805.

44. TakeshitaH, SawaH (2005) Asymmetric cortical and nuclear localizations of WRM-1/beta-catenin during asymmetric cell division in C. elegans. Genes Dev 19: 1743–1748.

45. MathiesLD, SchvarzsteinM, MorphyKM, BlellochR, SpenceAM, et al. (2004) TRA-1/GLI controls development of somatic gonadal precursors in C. elegans. Development 131: 4333–4343.

46. ChesneyMA, LamN, MorganDE, PhillipsBT, KimbleJ (2009) C. elegans HLH-2/E/Daughterless controls key regulatory cells during gonadogenesis. Dev Biol 331: 14–25.

47. KarpX, GreenwaldI (2003) Post-transcriptional regulation of the E/Daughterless ortholog HLH-2, negative feedback, and birth order bias during the AC/VU decision in C. elegans. Genes Dev 17: 3100–3111.

48. NawaM, Kage-NakadaiE, AisoS, OkamotoK, MitaniS, et al. (2012) Reduced expression of BTBD10, an Akt activator, leads to motor neuron death. Cell Death Differ 19: 1398–1407.

49. Thomas SP, Vinay K (2005) Neoplasia. In: Vinay K, Abul AK, Nelson F, Richard MN, editors. Pathologic Basis of Disease, Philadelphia: Elsevier Saunders. pp. 270–342.

50. ClemsonCM, HutchinsonJN, SaraSA, EnsmingerAW, FoxAH, et al. (2009) An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 33: 717–726.

51. AkaboshiS, WatanabeS, HinoY, SekitaY, XiY, et al. (2009) HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol 175: 1675–1685.

52. SafaAR (2012) c-FLIP, a master anti-apoptotic regulator. Exp Oncol 34: 176–184.

53. SafaAR, PollokKE (2011) Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers (Basel) 3: 1639–1671.

54. González de AguilarJL, GordonJW, RenéF, de TapiaM, Lutz-BucherB, et al. (2000) Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol Dis 7: 406–415.

55. FuchsY, StellerH (2011) Programmed cell death in animal development and disease. Cell 147: 742–758.

56. JacksonSP, BartekJ (2009) The DNA-damage response in human biology and disease. Nature 461: 1071–1078.

57. NegriniS, GorgoulisVG, HalazonetisTD (2010) Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220–228.

58. FishelR, LescoeMK, RaoMR, CopelandNG, JenkinsNA, et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027–1038.

59. FordD, EastonDF, BishopDT, NarodSA, GoldgarDE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692–695.

60. FordD, EastonDF, StrattonM, NarodS, GoldgarD, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–689.

61. MikiY, SwensenJ, Shattuck-EidensD, FutrealPA, HarshmanK, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

62. MorinPJ, SparksAB, KorinekV, BarkerN, CleversH, et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787–1790.

63. SuLK, VogelsteinB, KinzlerKW (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737.

64. HunterT, PinesJ (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573–582.

65. SherrCJ, RobertsJM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149–1163.

66. KadochC, HargreavesDC, HodgesC, EliasL, HoL, et al. (2013) Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45: 592–601.

67. ParkJI, VenteicherAS, HongJY, ChoiJ, JunS, et al. (2009) Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460: 66–72.

68. SawaH, KouikeH, OkanoH (2000) Components of the SWI/SNF complex are required for asymmetric cell division in C. elegans. Mol Cell 6: 617–624.

69. ShibataY, UchidaM, TakeshitaH, NishiwakiK, SawaH (2012) Multiple functions of PBRM-1/Polybromo- and LET-526/Osa-containing chromatin remodeling complexes in C. elegans development. Dev Biol 361: 349–357.

70. SawaH (2012) Control of cell polarity and asymmetric division in C. elegans. Current Topics in Developmental Biology 101: 55–76..

71. YamamotoY, TakeshitaH, SawaH (2011) Multiple Wnts redundantly control polarity orientation in Caenorhabditis elegans epithelial stem cells. PLoS Genet 7: e1002308.

72. MizumotoK, SawaH (2007) Cortical beta-catenin and APC regulate asymmetric nuclear beta-catenin localization during asymmetric cell division in C. elegans. Dev Cell 12: 287–299.

73. MizumotoK, SawaH (2007) Two betas or not two betas: regulation of asymmetric division by beta-catenin. Trends Cell Biol 17: 465–473.

74. GleasonJE, EisenmannDM (2010) Wnt signaling controls the stem cell-like asymmetric division of the epithelial seam cells during C. elegans larval development. Dev Biol 348: 58–66.

75. RenH, ZhangH (2010) Wnt signaling controls temporal identities of seam cells in Caenorhabditis elegans. Dev Biol 345: 144–155.

76. GaoD, KimbleJ (1995) APX-1 can substitute for its homolog LAG-2 to direct cell interactions throughout Caenorhabditis elegans development. Proc Natl Acad Sci U S A 92: 9839–9842.

77. PepperAS, KillianDJ, HubbardEJ (2003) Genetic analysis of Caenorhabditis elegans glp-1 mutants suggests receptor interaction or competition. Genetics 163: 115–132.

78. PepperAS, LoTW, KillianDJ, HallDH, HubbardEJ (2003) The establishment of Caenorhabditis elegans germline pattern is controlled by overlapping proximal and distal somatic gonad signals. Dev Biol 259: 336–350.

79. GreenblattMS, BennettWP, HollsteinM, HarrisCC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.

80. LiD, MarchenkoND, SchulzR, FischerV, Velasco-HernandezT, et al. (2011) Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res 9: 577–588.

81. LiuDP, SongH, XuY (2010) A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 29: 949–956.

82. MiyashitaT, HarigaiM, HanadaM, ReedJC (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131–3135.

83. MiyashitaT, KrajewskiS, KrajewskaM, WangHG, LinHK, et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799–1805.

84. SuLK, VogelsteinB, KinzlerKW (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737.

85. CuriaMC, De IureS, De LellisL, VeschiS, MammarellaS, et al. (2012) Increased variance in germline allele-specific expression of APC associates with colorectal cancer. Gastroenterology 142: 71–77.e71.

86. Al-HajjM, WichaMS, Benito-HernandezA, MorrisonSJ, ClarkeMF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983–3988.

87. KouzaridesT (2007) Chromatin modifications and their function. Cell 128: 693–705.

88. LiB, CareyM, WorkmanJL (2007) The role of chromatin during transcription. Cell 128: 707–719.

89. MurataniM, TanseyWP (2003) How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4: 192–201.

90. ZagerRA, JohnsonAC (2009) Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol 296: F1032–1041.

91. JeterCR, LiuB, LiuX, ChenX, LiuC, et al. (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Onocogene 30: 3833–3845.

92. BrennerS (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.

93. Gengyo-AndoK, MitaniS (2000) Characterization of mutations induced by ethyl methanesulfonate, UV, and trimethylpsoralen in the nematode Caenorhabditis elegans. Biochem Biophys Res Commun 269: 64–69.

94. Gengyo-AndoK, YoshinaS, InoueH, MitaniS (2006) An efficient transgenic system by TA cloning vectors and RNAi for C. elegans. Biochem Biophys Res Commun 349: 1345–1350.

95. StarichTA, HermanRK, KariCK, YehWH, SchackwitzWS, SchuylerMW, ColletJ, ThomasJH, RiddleDL (1995) Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics 139: 171–188.

96. MaruyamaR, EndoS, SugimotoA, YamamotoM (2005) Caenorhabditis elegans DAZ-1 is expressed in proliferating germ cells and directs proper nuclear organization and cytoplasmic core formation during oogenesis. Dev Biol 277: 142–154.

97. KamathRS, Martinez-CamposM, ZipperlenP, FraserAG, AhringerJ (2001) Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol 2: RESEARCH0002.

98. KoelleMR, HorvitzHR (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84: 115–125.

99. KoopmanG, ReutelingspergerCP, KuijtenGA, KeehnenRM, PalsST, et al. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415–1420.

100. LecoeurH, LedruE, PrévostMC, GougeonML (1997) Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods 209: 111–123.